ESR1 peptide vaccine (Duke University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameESR1 peptide vaccine (Duke University)

Drug Alias Nameestrogen receptor 1-based peptide vaccine (Duke University)

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesDuke University

China Registration ClassN/A

Develop Information

Active CompaniesDuke University

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A